We are live on ! Find out more
AC

Aisling Capital Portfolio holdings

AUM $45.3M
1-Year Est. Return 15.24%
This Fund
S&P 500
This Quarter Est. Return
-19.32%
1 Year Est. Return
-15.24%
3 Year Est. Return
+386.13%
5 Year Est. Return
+981.36%
10 Year Est. Return
–
AUM
$353M
AUM Growth
-$110M
Cap. Flow
-$11.4M
Cap. Flow %
-3.22%
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
VRAY
ViewRay, Inc.
VRAY
+$10.3M

Sector Composition

Rank Sector Weight
1 Healthcare 85.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LOXO
1
DELISTED
Loxo Oncology, Inc
LOXO
$286M 80.87%
2,038,920
– –
AIMT
2
DELISTED
Aimmune Therapeutics
AIMT
$47.6M 13.48%
1,990,000
– –
ADMA icon
3
ADMA Biologics
ADMA
$1.94B
$8.62M 2.44%
3,608,171
– –
ASXC
4
DELISTED
Asensus Surgical, Inc.
ASXC
$5.4M 1.53%
183,796
– –
CDTX
5
DELISTED
Cidara Therapeutics
CDTX
$2.4M 0.68%
51,057
– –
VRAY
6
DELISTED
ViewRay, Inc.
VRAY
$2.21M 0.63%
363,640
-1,372,348
-79% -$10.3M
CMRX
7
DELISTED
Chimerix, Inc.
CMRX
$1.22M 0.34%
472,943
– –
PTX
8
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$88K 0.02%
210,000
– –

Similar funds

SCPM
Sagard Capital Partners Management New York $46.7M AUM 23.43% 1-Year Est. Return
ZIM
ZPR Investment Management Orange City, Florida $46.8M AUM 2.45% 1-Year Est. Return
ACP
Aquiline Capital Partners New York $46.9M AUM 5.65% 1-Year Est. Return
INL
IPC/NYCG LLC New York $43.3M AUM 61.41% 1-Year Est. Return
CP
Clover Partners Dallas, Texas $43.1M AUM 4.09% 1-Year Est. Return
SAM
Sheffield Asset Management Chicago, Illinois $48.1M AUM 12.96% 1-Year Est. Return
JCM
Julex Capital Management Wellesley, Massachusetts $42.4M AUM 9.78% 1-Year Est. Return
GX
Greylock XII Menlo Park, California $51.9M AUM 11.52% 1-Year Est. Return

Aisling Capital's Q4 2018 Portfolio in Review

As of Q4 2018, Aisling Capital held 9 positions worth $353M, down 24% from $463M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Aisling Capital withdrew a net $11.4M in Q4 2018, reducing 1 holding. Its largest reduction was ViewRay, Inc., cutting an estimated $10.3M.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 85% a quarter earlier.

  • Aisling Capital's biggest Q4 2018 reduction was ViewRay, Inc., cutting an estimated $10.3M.
  • Aisling Capital's ten largest holdings make up 100% of its $353M portfolio in Q4 2018.
  • Aisling Capital opened 0 new positions and closed 0 in Q4 2018.
  • Aisling Capital's portfolio value fell 24% quarter-over-quarter to $353M.

Based on Aisling Capital's 13F filing for Q4 2018, filed 11 Feb 2019.